Merck & Co., Inc.
MRK XNYS
$146.94
-3.96 (-2.63%)
▼
15-min delayed
Open
$152.00
High
$153.37
Low
$146.54
Volume
11.55M
Market Cap
$370.96B
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
Earnings & Analyst Ratings
Next Earnings:
Tue, Feb 2, 2027
Calendar →
TickerDaily Coverage
Stock Market Today, October 18, 2026: Week Ahead Preview — Tech Earnings Dominate
Market News
David Brooks · Oct 19, 2026
The stock market heads into a pivotal earnings week with major tech and industrial names reporting....
Healthcare Stocks This Week: XLV Outpaces S&P 500 Amid Rate Pause Optimism (Oct 5–9, 2026)
Market News
David Brooks · Oct 9, 2026
The healthcare sector navigated a volatile week with conviction, as the XLV ETF gained 2.8% from...
Healthcare Stocks This Week: XLV Gains 2.1% as UNH, LLY Lead Sector Rally (Aug 3–7, 2026)
Market News
David Brooks · Aug 7, 2026
The healthcare sector finished the week with solid momentum, as the Health Care Select Sector SPDR...
Stock Market This Week: Earnings Preview for August 3-7, 2026 — Disney, Eli Lilly, Caterpillar Lead Earnings Deluge
Market News
David Brooks · Jul 27, 2026
The stock market enters earnings season's heaviest week with mega-cap reports from Disney, Eli...
Healthcare Stocks This Week: XLV Outperforms on Rate Cut Bets — Weekly Roundup (Jun 29 – Jul 3, 2026)
Market News
David Brooks · Jul 3, 2026
The healthcare sector capped a record-breaking first half with a strong week as XLV rallied on...
View All Coverage →
Get MRK Alerts
Stay ahead with breaking news, price alerts, and expert analysis on Merck & Co., Inc..
Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.